BioSpace News Archive

Noctrix Health, Inc. today announced that the first patient has been enrolled in a multi-center, randomized controlled clinical trial. The RESTFUL Study (ClinicalTrials.gov Identifier: NCT04874155)

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced that John Cullivan has joined the Company as a new member of the Executive Leadership Team in the role of Chief Corporate Development Officer.

CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, today announced that it will hold a webcast with the investment community on Thursday, May 27, at 5 p.m. Eastern Daylight Time.

Qosina is pleased to announce that it has entered into a distribution agreement with Nordson MEDICAL, a premier manufacturer and supplier of components to the bioprocess and medical device industries.

Elixirgen Therapeutics, Inc., a Baltimore -based biotechnology company focused on the discovery and development of therapies for genetic diseases and vaccines, today announced the dosing of the first and second participants in its COVID-19 vaccine Phase 1/2 Clinical Trial in Japan .

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Dion Neame has joined the company’s Strategic Advisory Board (SAB).

Apnimed, a clinical-stage pharmaceutical company focused on developing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that the Company’s management team will participate in the Jefferies Virtual Healthcare Conference, held June 1-4, 2021. Apnimed’s presentation is scheduled for Tuesday, June 1 st at 4:30pm ET.

LION Eye Group (“LION”) and Topology, a remote opticianry and 3D virtual-try-on (VTO) software company announced the intent to move forward with LION Express for its eyewear-focused “retail optometric stores.” LION is a fast-growing optometric network based in New York utilizing technology to create a more competitive, profitable, relevant and sustainable business.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced the pricing of an underwritten public offering of 2,857,143 shares of its common stock at a price to the public of $7.00 per share.

- Phase 3 Studies of Oral Insulin Underway and on Schedule - Oral COVID-19 Vaccine Clinical Trials Through Oravax Medical to Begin H2 2021